Skip to main content

Transcriptional Regulation of the p53 Tumor Suppressor Gene: A Potential Target for Cancer Therapeutics?

Buy Article:

$113.00 plus tax (Refund Policy)


The tightly regulated expression of p53 contributes to genomic stability and transcription of the p53 gene is induced prior to cells entering S-phase, possibly as a mechanism to insure a rapid p53 response in the event of DNA damage. We have previously described the cloning of an additional 1000bp of upstream p53 sequences that we have demonstrated play a role in the regulated expression of p53. As described in earlier reports we identified that a member of the C/EPB family of transcription factors may play a role in regulating p53. A particular C/EBPβ isoform, C/EBPβ-2, efficiently binds to the p53 promoter and induces its expression in a fashion that reflects the pattern of p53 expression seen as cells are induced to enter S-phase and is absent from cells that are defective in proper p53 regulation. We conclude from these findings that C/EBPβ-2 plays a central role in regulating p53 transcription during the transition into S-phase. The recent development of novel compounds that restore wild-type p53 activity to tumor cells raises the possibility that understanding the means by which p53 gene expression is deregulated in tumors cells could likely lead to the development of novel therapeutic strategies designed to return p53 to its normal expression.

Keywords: C/EBP; cell cycle regulated gene expression; p53 tumor suppressor; transcriptional regulation

Document Type: Research Article


Publication date: 2007-11-01

More about this publication?
  • Recent Patents on DNA and Gene Sequences publishes review articles by experts on recent patents on DNA and gene sequences. A selection of important and recent patents in the field is also included in the journal. The journal is essential reading for all researchers involved in applied molecular biology.
  • Access Key
  • Free ContentFree content
  • Partial Free ContentPartial Free content
  • New ContentNew content
  • Open Access ContentOpen access content
  • Partial Open Access ContentPartial Open access content
  • Subscribed ContentSubscribed content
  • Partial Subscribed ContentPartial Subscribed content
  • Free Trial ContentFree trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more